FUBT
VRTX icon

First United Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

First United Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$3.92K – 424
2025
Q3 		$3.92K Buy
+10
New +$4.18K ﹤0.01% 384

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First United Bank & Trust's VRTX Position: Q4 2025 in Review

First United Bank & Trust sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 10 shares — an estimated $3.92K sold.

First United Bank & Trust first reported a position in VRTX in Q3 2025 and held it in 1 quarter. The position peaked at $3.92K in Q3 2025. 1,669 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • First United Bank & Trust reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • First United Bank & Trust sold 10 Vertex Pharmaceuticals shares in Q4 2025, an estimated $3.92K.
  • First United Bank & Trust first reported a position in Vertex Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • First United Bank & Trust's Vertex Pharmaceuticals position peaked at $3.92K in Q3 2025.
  • 1,669 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on First United Bank & Trust's 13F filing for Q4 2025, filed 21 Jan 2026.